149341-31-1

Upstream product

• 123-82-0 (S)-2-heptylamine 
• 100-52-7 benzaldehyde 
• 592-76-7 1-Heptene 
• 100-46-9 benzylamine 
• 458560-69-5 (S)-3-benzyl-4-methyl-1,2,3-oxathiazolidine-2-oxide 
• 6940-80-3 (S)-N-benzylalaninol 
• 458560-71-9 (S)-3-benzyl-4-methyl-[1,2,3]-oxathiazolidine-2,2-dioxide 

Downstream Products

• 1026407-81-7 C₃₆H₄₃NO₃ 

Relevant academic research and scientific papers

Asymmetric Intra- and Intermolecular Hydroamination Catalyzed by 3,3′-Bis(trisarylsilyl)- and 3,3′-Bis(arylalkylsilyl)-Substituted Binaphtholate Rare-Earth-Metal Complexes

The series of novel 3,3′-bis(trisarylsilyl)- and 3,3′-bis(arylalkylsilyl)-substituted binaphtholate rare-earth-metal complexes 2a-i (SiR3 = Si(o-biphenylene)Ph (a), SiCyPh2 (b), Si-t-BuPh2 (c), Si(i-Pr)3 (d), SiCy2Ph (e), Si(2-tolyl)Ph2 (f), Si(4-t-Bu-C6H4)3 (g), Si(4-MeO-C6H4)Ph2 (h), SiBnPh2 (i)) have been prepared via arene elimination from [Ln(o-C6H4CH2NMe2)3] (Ln = Y, Lu) and the corresponding 3,3′-bis(silyl)-substituted binaphthol. The complexes exhibit high catalytic activity in the hydroamination/cyclization of aminoalkenes, with activities exceeding 1000 h-1 for (R)-2f-Ln, (R)-2g-Ln, and (R)-2h-Ln in the cyclization of 2,2-diphenylpent-4-enylamine (3a) at 25 °C, while the rigid dibenzosilole-substituted complexes (R)-2a-Ln and the triisopropylsilyl-substituted complexes (R)-2d-Ln exhibited the lowest activity in the range of 150-270 h-1. Catalysts (R)-2b-Lu, (R)-2c-Lu, (R)-2f-Lu, and (R)-2i-Lu provide the highest selectivities for the majority of the substrates, while the yttrium congeners are usually less selective. The highest enantioselectivities of 96% ee were observed using (R)-2a-Lu and (R)-2c-Lu in the cyclization of (4E)-2,2,5-triphenylpent-4-enylamine (9). The reactions show apparently zero-order rate dependence on substrate concentration and first-order rate dependence on catalyst concentration, with some reactions exhibiting a slightly accelerated rate at high conversion due to a shift in the equilibrium between a less active, higher coordinate catalyst species in favor of a more active, lower coordinate species as a result of weaker binding of the hydroamination product in comparison to the aminoalkene substrate. The shift in equilibrium from the higher to the lower coordinate species is also entropically favored at elevated temperatures, which results in an unusual increase in selectivity in the cyclization of 2,2-dimethylpent-4-enylamine (3d), presumably due to a higher selectivity of the lower coordinate catalyst species. All binaphtholate yttrium complexes, except (R)-2a-Y, are catalytically active in the intermolecular hydroamination of benzylamines with terminal alkenes. The highest selectivity of 66% ee was observed for the reaction of benzylamine with 4-phenyl-1-butene using (R)-2h-Y at 110 °C.

Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

This disclosure concerns the discovery of the use of fenoterol and (R,R)- and (R,S)-fenoterol analogs for the treatment of a tumor expressing a β2-adrenergic receptor, such as a primary brain tumor, including a glioblastoma or astrocytoma expressing a β2-adrenergic receptor. In one example, the method includes administering to a subject a therapeutically effective amount of fenoterol, a specific fenoterol analog or a combination thereof to reduce one or more symptoms associated with the tumor, thereby treating the tumor in the subject.

C1-symmetric rare-earth-metal aminodiolate complexes for intra- and intermolecular asymmetric hydroamination of alkenes

A series of novel C1-symmetric aminodiolate rare-earth-metal complexes have been prepared via arene elimination from [Ln(o-C 6H4CH2NMe2)3] (Ln = Y, Lu) and the corresponding aminodiol proligand. The NOBIN-derived aminodiolate ligands feature sterically demanding triphenylsilyl and methyldiphenylsilyl ortho substituents on the naphtholate moiety and substituents of varying steric demand ranging from tert-butyl to tris(3,5-xylyl)silyl on the phenolate moiety. Complexes with a triphenylsilyl substituent on the naphtholate moiety displayed good catalytic activity in the hydroamination/cyclization of aminoalkenes, while complexes with a methyldiphenylsilyl substituent exhibited somewhat lower reactivity. The highest enantioselectivities for five- and six-membered-ring formation were observed utilizing complex 9c-Lu (R1 = Ph, R 2 = Me, R3 = SiPh3) in the cyclization of (2,2-diphenylpent-4-enyl)amine (92% ee, Nt = 200 h-1 at 25 C) and (2,2-diphenylhex-5-enyl)amine (73% ee, Nt = 20 h-1 at 25 C). The complexes can be applied in asymmetric intermolecular hydroaminations of 1-heptene and 4-phenyl-1-butene with benzylamine with enantioselectivities of up to 40% ee using complex 9b-Y (R1 = Ph, R2 = Me, R3 = SiPh2Me). Here the higher catalytic activities are achieved with catalysts having a methyldiphenylsilyl substituent on the naphtholate moiety. Lanthanum aminodiolate catalysts generated in situ from [La{CH(C6H5)NMe2} 3] did not exhibit improved catalytic activity in the intermolecular hydroamination in comparison to the corresponding yttrium and lutetium catalysts. The overall catalytic activities of the aminodiolate complexes are somewhat diminished in comparison to previously studied binaphtholate complexes due to the presence of the additional amine donor site in the ligand framework.

Asymmetric intermolecular hydroamination of unactivated alkenes with simple amines

A hard nut to crack: The asymmetric intermolecular Markovnikov addition of simple amines to unactivated alkenes can be achieved utilizing binaphtholate rare-earth-metal catalysts with up to 61% ee and 73% de in the case where R 2 contains a stereogenic center.

PREPARATION OF (R,R)-FENOTEROL AND (R,R)- OR (R,S)-FENOTEROL ANALOGUES AND THEIR USE IN TREATING CONGESTIVE HEART FAILURE

This disclosure concerns the discovery of (R,R)- and (R,S)-fenoterol analogues which are highly effective at binding β2-adrenergic receptors. Exemplary chemical structures for these analogues are provided. Also provided are pharmaceutical compositions including the disclosed (R,R)-fenoterol and fenoterol analogues, and methods of using such compounds and compositions for the treatment of cardiac disorders such as congestive heart failure and pulmonary disorders such as asthma or chronic obstructive pulmonary disease.

Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the β2 adrenergic receptor

Stereoisomers of fenoterol and six fenoterol derivatives have been synthesized and their binding affinities for the β2 adrenergic receptor (Kiβ2-AR), the subtype selectivity relative to the β1-AR (Kiβ1-AR/K iβ2-AR) and their functional activities were determined. Of the 26 compounds synthesized in the study, submicromolar binding affinities were observed for (R,R)-fenoterol, the (R,R)-isomer of the p-methoxy, and (R,R)- and (R,S)-isomers of 1-naphthyl derivatives and all of these compounds were active at submicromolar concentrations in cardiomyocyte contractility tests. The Kiβ1-AR/K iβ2-AR ratios were >40 for (R,R)-fenoterol and the (R,R)-p-methoxy and (R,S)-1-naphthyl derivatives and 14 for the (R,R)-1-napthyl derivative. The binding data was analyzed using comparative molecular field analysis (CoMFA), and the resulting model indicated that the fenoterol derivatives interacted with two separate binding sites and one steric restricted site on the pseudo-receptor and that the chirality of the second stereogenic center affected Kiβ2 and subtype selectivity.

New carbon-carbon bond forming reactions of cyclic sulfate esters and cyclic sulfamidates

Carbon-carbon bonding forming reactions of two cyclic sulfate esters and a cyclic sulfamidate are reported, the former with lithium dianions to give substituted tetrahydrofuran derivatives with displacement of sulfate, and the latter undergoes ring-openin